4:30 PM ET
Form 4
Insider Selling
Rapport Therapeutics CEO Abraham Ceesay Sells $64.4K of Stock
Abraham Ceesay, CEO, sold 2,210 shares of Rapport Therapeutics, Inc. at $29.16 a share, worth $64.4K in total on Oct 21, 2026. Shares held after the trade: 450,035 (-0.5%).
- Value
- $64.4K
- Shares
- 2,210
- Price
- $29.16
- Role
- CEO
- Holding change
- -0.5%
- Trade date
- Oct 21, 2026